Envision Pharma Group

The Envision Pharma Group is an innovative scientific communications and technology company focused on the life science industry that works with clients, authors, and the medical publishing community to develop and execute evidence-based communication programs in a transparent and compliant manner. Envision supports clients across the product life cycle through a comprehensive suite of services and industry-leading technology solutions that include artificial intelligence and natural language processing, commercialization and integrated strategic consulting, evidence-based scientific communications and engagement, HEOR/market access and data analytics, medical capabilities, and omnichannel solutions

Greg Carpenter

Chief of Staff, CEO and member of the Executive Leadership Team

6 past transactions

doDOC Corporation

Acquisition in 2021
doDOC allows several people to work on the same document at the same time. Your team will plan, draft, edit, review and approve documents more than 70% faster. With well-governed workflows and granular permissions down to the paragraph-level, you will obtain a full audit-trail of any document. Founded by MIT alumni in 2015 and headquartered in Boston, doDOC is set to change the content collaboration paradigm by streamlining the writing and management experience, and automating all the technical aspects that undermine productivity. doDOC is a powerful and flexible cloud-based software, scaled to meet the needs of any business, from startups to global companies. Learn more at: https://www.doDOC.com

Two Labs

Acquisition in 2020
Two Labs is a leading pharmaceutical services company that provides a portfolio of market access, market intelligence and commercialization services to pharmaceutical manufacturers. Two Labs has led 200+ new product launches and more than 290 in-market projects from pre-launch to loss of exclusivity.

90 Ten

Acquisition in 2020
90TEN is an independent healthcare communications consultancy.

Touch Creative Design

Acquisition in 2017
Touch Creative Design is a Pharma/Healthcare focused agency with multi-industry experience – predominantly healthcare focused they also work across other industries. This experience keeps their ideas fresh, allowing them to evaluate and experiment with the latest technologies and learn what works with respect to customer engagement. Specialties include: Creative strategy development; Digital & technology-based experiences; Exhibitions and Event services; Branding and traditional creative media.

ProScribe

Acquisition in 2014
ProScribe is a company that was acquired by Envision Pharma Group in 2014.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.